Dod101 wrote:I really really really do not think we need yet another argument about the merits or otherwise of a HYP.
Dod
Indeed. To me, a bit like my current investment in IMB, its about whether enough free cash flow can come from the company and its product over the years, to compensate for a product (and company) that is ex-growth and might have difficulty maintaining the worth of its Capital. It's on my list for review given the trading update to judge the potential value of those cashflows (and dividends they will likely represent) against the current share price.